Compounds for treating MDS-associated anemias and other conditions
TW202631141APending Publication Date: 2026-08-01AGIOS PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-10-03
- Publication Date
- 2026-08-01
Smart Images
Figure 00000000_0000_ABST
Abstract
Provided herein is the use of particular dose levels or amounts of certain pyruvate kinase activators or pharmaceutically acceptable salts or compositions thereof, for treating anemia associated with low risk MDS, lower risk MDS and / or intermediate risk MDS (collectively, LR-MDS) and other conditions.
Need to check novelty before this filing date? Find Prior Art